Cascadia Healthcare

cascadiahc.com

Cascadia was formed when partners from the skilled nursing and real estate development industry joined forces with a common purpose in mind – to provide a high level of care to patients and families within the region they call home. Our goal is to provide a motivating environment for our employees based on the values of quality work, empowerment and accountability. Cascadia is driven by honest hard work and we believe that strong partnerships and quality care are the outcome.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

TWIST BIOSCIENCE EXPANDS EXPRESS GENES RAPID SYNTHESIS SERVICE

Twist Bioscience Corporation | January 30, 2024

news image

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days1, to include larger DNA preparations up to 1 milligram. The Express Genes offering, initially launched in November 2023, now extends to larger midiprep (10μg to 100 μg) a...

Read More

Industrial Impact, Medical

SOPHIA AND MSKCC PARTNER TO COMBINE CANCER ANALYSIS TECHNOLOGY FOR LIQUID BIOPSIES

SOPHiA GENETICS | January 13, 2023

news image

SOPHiA GENETICSTM, a leading cloud-native software firm in the healthcare industry, recently announced that it has partnered with Memorial Sloan Kettering Cancer Center (MSKCC) to provide physicians and researchers with new testing and analytic capabilities. The collaboration includes the incorporation of proprietary Comprehensive Genomic Panel (CGP) sequencing tests, such as MSK-ACCESS®, which SOPHiA GENETICS will market as the first comprehensive ctDNA liquid biopsy test p...

Read More

Cell and Gene Therapy

KANEKA EUROGENTEC ANNOUNCES THE SUCCESSFUL PRODUCTION OF 25G OF MRNA IN ONE BATCH

Kaneka Eurogentec | February 23, 2022

news image

Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for a US customer. Eurogentec’s GMP mRNA manufacturing service offers in vitro transcription (IVT), purification, quality control and batch release of GMP material up to 25 g scale in its current facility in Belgium. In this project Eurogentec successfully produced and purified 25 g of mate...

Read More

Medical, Industry Outlook

ERS GENOMICS & SANTA CRUZ BIOTECHNOLOGY ENTER INTO CRISPR/CAS9 LICENSING AGREEMENT

PRNewswire | August 14, 2023

news image

ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Santa Cruz Biotechnology Inc ('SCBT,'). This is a non-exclusive licensing agreement granting SCBT access to the ERS CRISPR/Cas9 patent portfolio. ERS founder, Dr. Emmanuelle Charpentier, won the 2020 Nobel Prize for the discovery of CRISPR/Cas9. Consequently, the ERS patent portfolio is the most comprehensive collection of proprietary rights to this gene editing technology. ...

Read More
news image

Medical

TWIST BIOSCIENCE EXPANDS EXPRESS GENES RAPID SYNTHESIS SERVICE

Twist Bioscience Corporation | January 30, 2024

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days1, to include larger DNA preparations up to 1 milligram. The Express Genes offering, initially launched in November 2023, now extends to larger midiprep (10μg to 100 μg) a...

Read More
news image

Industrial Impact, Medical

SOPHIA AND MSKCC PARTNER TO COMBINE CANCER ANALYSIS TECHNOLOGY FOR LIQUID BIOPSIES

SOPHiA GENETICS | January 13, 2023

SOPHiA GENETICSTM, a leading cloud-native software firm in the healthcare industry, recently announced that it has partnered with Memorial Sloan Kettering Cancer Center (MSKCC) to provide physicians and researchers with new testing and analytic capabilities. The collaboration includes the incorporation of proprietary Comprehensive Genomic Panel (CGP) sequencing tests, such as MSK-ACCESS®, which SOPHiA GENETICS will market as the first comprehensive ctDNA liquid biopsy test p...

Read More
news image

Cell and Gene Therapy

KANEKA EUROGENTEC ANNOUNCES THE SUCCESSFUL PRODUCTION OF 25G OF MRNA IN ONE BATCH

Kaneka Eurogentec | February 23, 2022

Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization announced today that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for a US customer. Eurogentec’s GMP mRNA manufacturing service offers in vitro transcription (IVT), purification, quality control and batch release of GMP material up to 25 g scale in its current facility in Belgium. In this project Eurogentec successfully produced and purified 25 g of mate...

Read More
news image

Medical, Industry Outlook

ERS GENOMICS & SANTA CRUZ BIOTECHNOLOGY ENTER INTO CRISPR/CAS9 LICENSING AGREEMENT

PRNewswire | August 14, 2023

ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Santa Cruz Biotechnology Inc ('SCBT,'). This is a non-exclusive licensing agreement granting SCBT access to the ERS CRISPR/Cas9 patent portfolio. ERS founder, Dr. Emmanuelle Charpentier, won the 2020 Nobel Prize for the discovery of CRISPR/Cas9. Consequently, the ERS patent portfolio is the most comprehensive collection of proprietary rights to this gene editing technology. ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us